Pfizer Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $976.0M | $1.70B | $1.14B | $1.34B | $1.64B | $1.43B | $1.04B | $1.09B |
| Accounts Receivable | $12.49B | $12.59B | $11.87B | $14.26B | $12.08B | $11.85B | $11.46B | $14.45B |
| Inventory | $9.95B | $10.67B | $10.65B | $11.47B | $11.67B | $10.85B | $10.85B | $11.72B |
| Total Current Assets | $41.36B | $42.82B | $42.90B | $46.92B | $43.70B | $45.86B | $50.36B | $43.22B |
| Property, Plant & Equipment | $19.03B | $19.40B | $19.32B | $18.88B | $18.78B | $18.35B | $18.39B | $18.54B |
| Goodwill | $71.42B | $71.41B | $71.26B | $69.10B | $69.00B | $68.44B | $68.53B | $68.57B |
| Intangible Assets (Excl. Goodwill) | $47.05B | $52.56B | $53.73B | $51.32B | $52.70B | $53.98B | $55.41B | $59.99B |
| Total Assets | $201.13B | $207.62B | $208.16B | $208.73B | $206.10B | $208.03B | $213.40B | $219.48B |
| Liabilities | ||||||||
| Accounts Payable | $4.58B | $4.51B | $5.24B | $5.02B | $5.17B | $5.24B | $5.63B | $5.31B |
| Total Current Liabilities | $32.65B | $34.35B | $36.98B | $36.60B | $37.73B | $36.45B | $43.00B | $43.21B |
| Long-Term Debt | $60.50B | $60.57B | $61.64B | $57.41B | $57.50B | $57.64B | $57.41B | $58.00B |
| Total Liabilities | $115.64B | $117.21B | $121.39B | $115.64B | $117.08B | $117.39B | $124.90B | $126.92B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $112.09B | $117.24B | $114.61B | $121.15B | $117.61B | $119.59B | $116.73B | $121.06B |
| Total Stockholders' Equity | $85.19B | $90.10B | $86.48B | $92.80B | $88.70B | $90.34B | $88.20B | $92.29B |